Results 271 to 280 of about 872,427 (309)

Atypical infections during combination therapy with anifrolumab and other immunosuppressives in patients with lupus erythematosus: A case series

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Shae Chambers   +8 more
wiley   +1 more source

Uhrf1 downregulation promotes β‐cell dedifferentiation by decreasing Foxo1 expression in type 2 diabetes

open access: yesJournal of Diabetes Investigation, EarlyView.
This finding reveals the important role of Uhrf1 in the β‐cell dedifferentiation of T2D, providing a potential target for its treatment. ABSTRACT Background Islet β‐cell dedifferentiation is a major pathological mechanism of type 2 diabetes (T2D). Forkhead box o1 (Foxo1) is a master regulator of β‐cell dedifferentiation.
Lanfang Fu   +3 more
wiley   +1 more source

IgG glycosylation profiling of systemic lupus erythematosus using lectin microarray. [PDF]

open access: yesLupus Sci Med
Wu Y   +10 more
europepmc   +1 more source

Targeting mechanistic target of rapamycin complex 2 attenuates immunopathology in systemic lupus erythematosus. [PDF]

open access: yesRheumatology (Oxford)
Ai M   +9 more
europepmc   +1 more source

Alopecia Areata and Systemic Lupus Erythematosus: Insights From a Nationwide Case–Control Study

open access: yes
International Journal of Dermatology, EarlyView.
Yonit Wohl   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy